These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 33636524)

  • 1. The prognostic significance of FOXC2 gene expression in cancer: A comprehensive analysis of RNA-seq data from the cancer genome atlas.
    Hargadon KM; Győrffy B; Strong EW
    Cancer Genet; 2021 Jun; 254-255():58-64. PubMed ID: 33636524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nuclear localization of GLI1 and elevated expression of FOXC2 in breast cancer is associated with the basal-like phenotype.
    Li Y; Yang W; Yang Q; Zhou S
    Histol Histopathol; 2012 Apr; 27(4):475-84. PubMed ID: 22374725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The FOXC2 Transcription Factor Promotes Melanoma Outgrowth and Regulates Expression of Genes Associated With Drug Resistance and Interferon Responsiveness.
    Hargadon KM; Györffy B; Strong EW; Tarnai BD; Thompson JC; Bushhouse DZ; Johnson CE; Williams CJ
    Cancer Genomics Proteomics; 2019; 16(6):491-503. PubMed ID: 31659103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The FOXC2 Transcription Factor: A Master Regulator of Chemoresistance in Cancer.
    Hargadon KM; Strong EW
    Technol Cancer Res Treat; 2023; 22():15330338231155284. PubMed ID: 36740986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic role of Twist, Slug, and Foxc2 expression in stage I non-small-cell lung cancer after curative resection.
    Jiang W; Pang XG; Wang Q; Shen YX; Chen XK; Xi JJ
    Clin Lung Cancer; 2012 Jul; 13(4):280-7. PubMed ID: 22178381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of high FoxC2 expression in resectable non-small cell lung cancer, alone or in combination with E-cadherin expression.
    Jiang W; Fan H; Qian C; Ding J; Wang Q; Pang X
    BMC Cancer; 2016 Jan; 16():16. PubMed ID: 26758745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncogenic functions of the FOXC2 transcription factor: a hallmarks of cancer perspective.
    Hargadon KM; Goodloe TB; Lloyd ND
    Cancer Metastasis Rev; 2022 Dec; 41(4):833-852. PubMed ID: 35701636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long Noncoding RNA FOXC2-AS1 Predicts Poor Survival in Breast Cancer Patients and Promotes Cell Proliferation.
    Yang H; Chen T; Xu S; Zhang S; Zhang M
    Oncol Res; 2019 Feb; 27(2):219-226. PubMed ID: 29562954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FOXF2 suppresses the FOXC2-mediated epithelial-mesenchymal transition and multidrug resistance of basal-like breast cancer.
    Cai J; Tian AX; Wang QS; Kong PZ; Du X; Li XQ; Feng YM
    Cancer Lett; 2015 Oct; 367(2):129-37. PubMed ID: 26210254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meta-analysis of the prognostic significance of FOXC2 in various tumors.
    Xu B; Tian Y; Liu L
    J Int Med Res; 2020 Mar; 48(3):300060519891648. PubMed ID: 31854217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High expression of forkhead box protein C2 is associated with aggressive phenotypes and poor prognosis in clinical hepatocellular carcinoma.
    Shimoda Y; Ubukata Y; Handa T; Yokobori T; Watanabe T; Gantumur D; Hagiwara K; Yamanaka T; Tsukagoshi M; Igarashi T; Watanabe A; Kubo N; Araki K; Harimoto N; Katayama A; Hikino T; Sano T; Ogata K; Kuwano H; Shirabe K; Oyama T
    BMC Cancer; 2018 May; 18(1):597. PubMed ID: 29801468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In silico screening using bulk and single-cell RNA-seq data identifies RIMS2 as a prognostic marker in basal-like breast cancer: A retrospective study.
    Zhang L; Liu Z; Zhu J
    Medicine (Baltimore); 2021 Apr; 100(16):e25414. PubMed ID: 33879671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated FOXC2 Expression Promotes Invasion of HCC Cell Lines and is Associated with Poor Prognosis in Hepatocellular Carcinoma.
    Yang F; Lv L; Zhang K; Cai Q; Liu J; Jiang Y
    Cell Physiol Biochem; 2017; 44(1):99-109. PubMed ID: 29131008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High expression of forkhead box protein C2 is related to poor prognosis in human gliomas.
    Wang YW; Yin CL; Zhang HY; Hao J; Yang YY; Liao H; Jiao BH
    Asian Pac J Cancer Prev; 2014; 15(24):10621-5. PubMed ID: 25605149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FOXC2 expression and epithelial-mesenchymal phenotypes are associated with castration resistance, metastasis and survival in prostate cancer.
    Børretzen A; Gravdal K; Haukaas SA; Beisland C; Akslen LA; Halvorsen OJ
    J Pathol Clin Res; 2019 Oct; 5(4):272-286. PubMed ID: 31464093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FOXC2 expression is associated with tumor proliferation and invasion potential in oral tongue squamous cell carcinoma.
    Imayama N; Yamada S; Yanamoto S; Naruse T; Matsushita Y; Takahashi H; Seki S; Fujita S; Ikeda T; Umeda M
    Pathol Oncol Res; 2015 Jul; 21(3):783-91. PubMed ID: 25573594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FOXC2 and CLIP4 : a potential biomarker for synchronous metastasis of ≤7-cm clear cell renal cell carcinomas.
    Ahn J; Han KS; Heo JH; Bang D; Kang YH; Jin HA; Hong SJ; Lee JH; Ham WS
    Oncotarget; 2016 Aug; 7(32):51423-51434. PubMed ID: 27283491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship between gene expression of Forkhead box C2 and tumor progression in cervical carcinoma.
    Cai L; Liu D; Lu S; Xu Y; Wang H
    Eur J Gynaecol Oncol; 2014; 35(6):625-30. PubMed ID: 25556265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Forkhead Box Protein C2 (FOXC2) Promotes the Resistance of Human Ovarian Cancer Cells to Cisplatin In Vitro and In Vivo.
    Li C; Ding H; Tian J; Wu L; Wang Y; Xing Y; Chen M
    Cell Physiol Biochem; 2016; 39(1):242-52. PubMed ID: 27336949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FOXC2 is up-regulated in pancreatic ductal adenocarcinoma and promotes the growth and migration of cancer cells.
    Cui L; Dang S; Qu J; Mao Z; Wang X; Zhang J; Chen J
    Tumour Biol; 2016 Jul; 37(7):8579-85. PubMed ID: 26733175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.